HIGHLIGHTS
- who: Lingyi Li from the , Canada have published the research work: Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study, in the Journal: (JOURNAL) of December/31,/2013
- what: As there is no effective treatment available that can halt OA progression, the main goal of medical therapy for managing OA is to control pain while avoiding therapeutic toxicity .
- how: This study aimed to determine if tramadol initiation is associated with an increased risk of all-cause mortality as well as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.